Login
$LYEL
$14.65 +$0.35 (2.45%) Live

$LYEL 4 SEC Filings

Filed On Filing
12 Nov 2026 Form 4: Lee Gary K., Chief Scientific Officer

Sold 129 shares ($2.05K)

12 Nov 2026 Form 4: Hill Stephen J., Chief Operating Officer

Sold 88 shares ($1.4K)

12 Nov 2026 Form 4: Seely Lynn, Director

Sold 545 shares ($8.68K)

12 Nov 2026 Form 4: Bulis Veronica Sanchez, VP, Corporate Controller

Sold 416 shares ($6.63K)

05 Nov 2026 Form 4: Arch Venture Partners IX, Llc, 10% owner and 4 others

Bought 2,321,262 shares ($25M)

05 Nov 2026 Form 4: Arch Venture Fund XIII, L.p., 10% owner and 8 others

Bought 2,321,262 shares ($25M)

13 Oct 2026 Form 4: Aguirre Jarrad Mattieu, Chief Medical Officer

Sold 422 shares ($3.64K)

10 Sep 2026 Form 4: Shook David, Chief Medical Officer

Sold 500 shares ($6.35K)

10 Sep 2026 Form 4: Aguirre Jarrad Mattieu, Chief Medical Officer

Granted 47,500 Option (right to buy)

25 Aug 2026 Form 4: Seely Lynn, Director

Sold 9,589 shares ($149K)

25 Aug 2026 Form 4: Hill Stephen J., Chief Operating Officer

Sold 989 shares ($15.4K)

25 Aug 2026 Form 4: Lee Gary K., Chief Scientific Officer

Sold 1,457 shares ($22.6K)

11 Aug 2026 Form 4: Bulis Veronica Sanchez, VP, Corporate Controller

Sold 621 shares ($8.91K)

11 Aug 2026 Form 4: Lee Gary K., Chief Scientific Officer

Sold 131 shares ($1.88K)

11 Aug 2026 Form 4: Hill Stephen J., Chief Operating Officer

Sold 89 shares ($1.28K)

11 Aug 2026 Form 4: Seely Lynn, Director

Sold 390 shares ($5.59K)

27 Jul 2026 Form 4: Innovative Cellular Therapeutics Holdings Ltd, 10% owner

Disposed of 44,000 shares (Other Transaction)

27 Jul 2026 Form 4: Innovative Cellular Therapeutics Holdings Ltd, 10% owner

Disposed of 38,500 shares (Other Transaction)

20 Jul 2026 Form 4: Innovative Cellular Therapeutics Holdings Ltd, 10% owner

Sold 10 shares ($137)

17 Jul 2026 Form 4: Innovative Cellular Therapeutics Holdings Ltd, 10% owner

Sold 10 shares ($137)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support